Summary
This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.
The report includes as follows:
The report provides current data, historical overview and future forecast.
The report includes an in-depth analysis of the Global market for Next Generation Cancer Diagnostics , covering Global total and major region markets.
The data of 2017-2025 are included. All-inclusive market are given through data on sales, consumption, and prices (Global total and by major regions).
The report provides introduction of leading Global manufacturers.
Next Generation Cancer Diagnostics market prospects to 2025 are included (in sales, consumption and price).
Market Segment as follows:
By Region / Countries
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc)
Asia-Pacific (China, India, Japan, Southeast Asia etc)
South America (Brazil, Argentina etc)
Middle East & Africa (Saudi Arabia, South Africa etc)
By Type
Next Generation Sequencing
qPCR & Multiplexing
DNA Microarrays
Others
By End-User / Application
Hospitals
Clinics
Others
By Company
Cepheid
Koninklijke Philips N.V
F. Hoffmann-La Roche Ltd
Qiagen
Novartis AG
Abbott
Thermo Fisher Scientific
Opko Health
Myriad Genetics
Agilent Technologies
GE Healthcare
PerkinElmer
Genomic Health
Illumina
Hologic
Almac Group
Janssen Global Services
Sysmex Corporation
Table of Contents
Part 1 Market Definition
1.1 Market Segment Overview
Figure Global Next Generation Cancer Diagnostics Market Size (Million USD) 2017-2025
1.2 by Type
Table Global Next Generation Cancer Diagnostics Market and Growth by Type
1.3 by End-Use / Application
Table Global Next Generation Cancer Diagnostics Market and Growth by End-Use / Application
2 Global Market by Vendors
2.1 Market Share
Table Global Next Generation Cancer Diagnostics Revenue (Million USD) by Vendors (2017-2019)
Table Global Next Generation Cancer Diagnostics Revenue Share by Vendors (2017-2019)
Table Global Next Generation Cancer Diagnostics Market Volume (Volume) by Vendors (2017-2019)
Table Global Next Generation Cancer Diagnostics Market Volume Share by Vendors (2017-2019)
2.2 Vendor Profile
Table Headquarter, Factories & Sales Regions Comparison of Vendors
Table Product List of Vendors
2.3 Dynamic of Vendors
3 Global Market by Type
3.1 Market Share
Table Global Next Generation Cancer Diagnostics Market (Million USD) by Type (2017-2019)
Table Global Next Generation Cancer Diagnostics Market Share by Type (2017-2019)
Table Global Next Generation Cancer Diagnostics Market Volume (Volume) by Type (2017-2019)
Table Global Next Generation Cancer Diagnostics Market Volume Share by Type (2017-2019)
3.2 Introduction of End-Use by Different Products
4 Global Market by End-Use / Application
4.1 Market Share
Table Global Next Generation Cancer Diagnostics Market (Million USD) by End-Use / Application (2017-2019)
Table Global Next Generation Cancer Diagnostics Market Share by End-Use / Application (2017-2019)
Table Global Next Generation Cancer Diagnostics Market Volume (Volume) by End-Use / Application (2017-2019)
Table Global Next Generation Cancer Diagnostics Market Volume Share by End-Use / Application (2017-2019)
4.2 Overview of Consumption Characteristics
4.2.1 Preference Driven
4.2.2 Substitutability
4.2.3 Influence by Strategy
4.2.4 Professional Needs
5 Global Market by Regions
5.1 Market Share
Table Global Next Generation Cancer Diagnostics Market (Million USD) by Regions (2017-2019)
Table Global Next Generation Cancer Diagnostics Market Share by Regions (2017-2019)
Table Global Next Generation Cancer Diagnostics Market Volume (Volume) by Regions (2017-2019)
Table Global Next Generation Cancer Diagnostics Market Volume Share by Regions (2017-2019)
5.2 Regional Market Growth
5.2.1 North America
Figure North America Market Growth 2015-2018
5.2.2 Europe
Figure Europe Market Growth 2017-2019
5.2.3 Asia-Pacific
Figure Asia-Pacific Market Growth 2017-2019
5.2.4 South America
Figure South America Market Growth 2017-2019
5.2.5 Middle East & Africa
Figure Middle East & Africa Market Growth 2017-2019
6 North America Market
6.1 by Type
Table North America Next Generation Cancer Diagnostics Market (Million USD) by Type (2017-2019)
Table North America Next Generation Cancer Diagnostics Market Share by Type (2017-2019)
6.2 by End-Use / Application
Table North America Next Generation Cancer Diagnostics Market (Million USD) by End-Use / Application (2017-2019)
Table North America Next Generation Cancer Diagnostics Market Share by End-Use / Application (2017-2019)
6.3 by Regions
Table North America Next Generation Cancer Diagnostics Market (Million USD) by Regions (2017-2019)
Table North America Next Generation Cancer Diagnostics Market Share by Regions (2017-2019)
7 Europe Market
7.1 by Type
Table Europe Next Generation Cancer Diagnostics Market (Million USD) by Type (2017-2019)
Table Europe Next Generation Cancer Diagnostics Market Share by Type (2017-2019)
7.2 by End-Use / Application
Table Europe Next Generation Cancer Diagnostics Market (Million USD) by End-Use / Application (2017-2019)
Table Europe Next Generation Cancer Diagnostics Market Share by End-Use / Application (2017-2019)
7.3 by Regions
Table Europe Next Generation Cancer Diagnostics Market (Million USD) by Regions (2017-2019)
Table Europe Next Generation Cancer Diagnostics Market Share by Regions (2017-2019)
8 Asia-Pacific Market
8.1 by Type
Table Asia-Pacific Next Generation Cancer Diagnostics Market (Million USD) by Type (2017-2019)
Table Asia-Pacific Next Generation Cancer Diagnostics Market Share by Type (2017-2019)
8.2 by End-Use / Application
Table Asia-Pacific Next Generation Cancer Diagnostics Market (Million USD) by End-Use / Application (2017-2019)
Table Asia-Pacific Next Generation Cancer Diagnostics Market Share by End-Use / Application (2017-2019)
8.3 by Regions
Table Asia-Pacific Next Generation Cancer Diagnostics Market (Million USD) by Regions (2017-2019)
Table Asia-Pacific Next Generation Cancer Diagnostics Market Share by Regions (2017-2019)
9 South America Market
9.1 by Type
Table South America Next Generation Cancer Diagnostics Market (Million USD) by Type (2017-2019)
Table South America Next Generation Cancer Diagnostics Market Share by Type (2017-2019)
9.2 by End-Use / Application
Table South America Next Generation Cancer Diagnostics Market (Million USD) by End-Use / Application (2017-2019)
Table South America Next Generation Cancer Diagnostics Market Share by End-Use / Application (2017-2019)
9.3 by Regions
Table South America Next Generation Cancer Diagnostics Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Next Generation Cancer Diagnostics Market Share by Regions (2017-2019)
10 Middle East & Africa Market
10.1 by Type
Table Middle East & Africa Next Generation Cancer Diagnostics Market (Million USD) by Type (2017-2019)
Table Middle East & Africa Next Generation Cancer Diagnostics Market Share by Type (2017-2019)
10.2 by End-Use / Application
Table Middle East & Africa Next Generation Cancer Diagnostics Market (Million USD) by End-Use / Application (2017-2019)
Table Middle East & Africa Next Generation Cancer Diagnostics Market Share by End-Use / Application (2017-2019)
10.3 by Regions
Table Middle East & Africa Next Generation Cancer Diagnostics Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Next Generation Cancer Diagnostics Market Share by Regions (2017-2019)
11 Market Forecast
11.1 Global Market Forecast (2020-2025)
Figure Global Next Generation Cancer Diagnostics Market (Million USD) and Growth Forecast (2020-2025)
Figure Global Next Generation Cancer Diagnostics Market Volume (Volume) and Growth Forecast (2020-2025)
11.2 Market Forecast by Regions (2020-2025)
Table Global Next Generation Cancer Diagnostics Market (Million USD) Forecast by Regions (2020-2025)
Table Global Next Generation Cancer Diagnostics Market Share Forecast by Regions (2020-2025)
Table Global Next Generation Cancer Diagnostics Market Volume (Volume) Forecast by Regions (2020-2025)
Table Global Next Generation Cancer Diagnostics Market Volume Share Forecast by Regions (2020-2025)
11.3 Market Forecast by Type (2020-2025)
Table Global Next Generation Cancer Diagnostics Market (Million USD) Forecast by Type (2020-2025)
Table Global Next Generation Cancer DiagnosticsMarket Share by Forecast Type (2020-2025)
11.4 Market Forecast by End-Use / Application (2020-2025)
Table Global Next Generation Cancer Diagnostics Market (Million USD) Forecast by End-Use / Application (2020-2025)
Table Global Next Generation Cancer Diagnostics Market Share Forecast by End-Use / Application (2020-2025)
12 Key Manufacturers
12.Dell EMC Cepheid
12.1.2 Company Overview
12.1.2 Product and End-User / Application
12.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Table Sales Revenue, Volume, Price, Cost and Margin of Cepheid
12.2 Koninklijke Philips N.V
12.3 F. Hoffmann-La Roche Ltd
12.4 Qiagen
12.5 Novartis AG
12.6 Abbott
12.7 Thermo Fisher Scientific
12.8 Opko Health
12.9 Myriad Genetics
12.10 Agilent Technologies
12.11 GE Healthcare
12.12 PerkinElmer
12.13 Genomic Health
12.14 Illumina
12.15 Hologic
12.16 Almac Group
12.17 Janssen Global Services
12.18 Sysmex Corporation
13 Overview of Industry Development (COVID-19)
13.1 Analysis of Industry Development (COVID-19)
13.2 Industry Development Stage (COVID-19)
13.3 General Situation of Industry Development (COVID-19)
13.4 Analysis of Industry Development Characteristics (COVID-19)
14 Research Conclusion
Price : US$ 3500 |
Date : Mar 2024 |
Category : Services |
Pages : 124 |